High laser powers are common practice in single molecule localization microscopy (SMLM) to speed up data acquisition. Here, we systematically quantified how excitation intensity influences localization precision and labeling density, the two main factors determining data quality. We found a strong trade-off between imaging speed and quality and present optimized imaging protocols for high-throughput, multi-color and 3D SMLM with greatly improved resolution and effective labeling efficiency.
The binding strength
between epithelial cells is crucial for tissue
integrity, signal transduction and collective cell dynamics. However,
there is no experimental approach to precisely modulate cell–cell
adhesion strength at the cellular and molecular level. Here, we establish
DNA nanotechnology as a tool to control cell–cell adhesion
of epithelial cells. We designed a DNA-E-cadherin hybrid system consisting
of complementary DNA strands covalently bound to a truncated E-cadherin
with a modified extracellular domain. DNA sequence design allows to
tune the DNA-E-cadherin hybrid molecular binding strength, while retaining
its cytosolic interactions and downstream signaling capabilities.
The DNA-E-cadherin hybrid facilitates strong and reversible cell–cell
adhesion in E-cadherin deficient cells by forming mechanotransducive
adherens junctions. We assess the direct influence of cell–cell
adhesion strength on intracellular signaling and collective cell dynamics.
This highlights the scope of DNA nanotechnology as a precision technology
to study and engineer cell collectives.
Altered endocytosis and vesicular trafficking are major players during tumorigenesis. Flotillin overexpression, a feature observed in many invasive tumors and identified as a marker of poor prognosis, induces a deregulated endocytic and trafficking pathway called upregulated flotillin-induced trafficking (UFIT). Here, we found that in non-tumoral mammary epithelial cells, induction of the UFIT pathway promotes epithelial-to-mesenchymal transition (EMT) and accelerates the endocytosis of several transmembrane receptors, including AXL, in flotillin-positive late endosomes. AXL overexpression, frequently observed in cancer cells, is linked to EMT and metastasis formation. In flotillin-overexpressing non-tumoral mammary epithelial cells and in invasive breast carcinoma cells, we found that the UFIT pathway-mediated AXL endocytosis allows its stabilization and depends on sphingosine kinase 2, a lipid kinase recruited in flotillin-rich plasma membrane domains and endosomes. Thus, the deregulation of vesicular trafficking following flotillin upregulation, and through sphingosine kinase 2, emerges as a new mechanism of AXL overexpression and EMT-inducing signaling pathway activation.
Molecular motors
are pivotal for intracellular transport as well
as cell motility and have great potential to be put to use outside
cells. Here, we exploit engineered motor proteins in combination with
self-assembly of actin filaments to actively pull lipid nanotubes
from giant unilamellar vesicles (GUVs). In particular, actin filaments
are bound to the outer GUV membrane and the GUVs are seeded on a heavy
meromyosin-coated substrate. Upon addition of ATP, hollow lipid nanotubes
with a length of tens of micrometer are pulled from single GUVs due
to the motor activity. We employ the same mechanism to pull lipid
nanotubes from different types of cells. We find that the length and
number of nanotubes critically depends on the cell type, whereby suspension
cells form bigger networks than adherent cells. This suggests that
molecular machines can be used to exert forces on living cells to
probe membrane-to-cortex attachment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.